Shanghai Kehua Bioengineering Co., Ltd. (Kehua Bio), founded in 1981 and listed on the Shenzhen Stock Exchange’s SME Board in 2004 (stock code: 002022.SZ), is an in vitro diagnostics company integrating R&D, production, and sales, with extensive production experience and a comprehensive portfolio of medical diagnostic products.

Over the past 40 years, Kehua Bio has received numerous honors, including the “Shanghai Famous Trademark Certificate,” “Shanghai Famous Brand,” “Shanghai Science and Technology Award (Controllable Preparation Technology of Magnetic Nanospheres and Molecular Diagnostic Kits),” “Shanghai Innovative Enterprise,” and “China’s Top 100 Innovative Small and Medium Enterprises.”

Kehua Bio, with its mission of “Caring for Life, Pursuing Excellence” and its vision of becoming a leading player in the IVD field, adheres to its corporate values ​​of “Customer First, Innovation, Collaboration, Responsibility, and Pragmatism.” Focusing on the in vitro diagnostics field, Kehua is committed to innovation and lean management, striving to contribute to human health.